HEALSTACK LTD

Company Registration Number:
12153452 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2023

Period of accounts

Start date: 01 September 2022

End date: 31 August 2023

HEALSTACK LTD

Contents of the Financial Statements

for the Period Ended 31 August 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 10

HEALSTACK LTD

Company Information

for the Period Ended 31 August 2023




Director: Victor Jansson
Jelena Vukosav
Registered office: 86-90
Paul Street
3rd Floor
London
England
EC2A 4NE
Company Registration Number: 12153452 (England and Wales)

HEALSTACK LTD

Balance sheet

As at 31 August 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 5 4,174 6,238
Total fixed assets: 4,174 6,238
Current assets
Stocks: 0 0
Debtors: 6 140 0
Cash at bank and in hand: 38,848 89,681
Total current assets: 38,988 89,681
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 7 ( 4,318 ) ( 31,560 )
Net current assets (liabilities): 34,670 58,121
Total assets less current liabilities: 38,844 64,359
Total net assets (liabilities): 38,844 64,359

The notes form part of these financial statements

HEALSTACK LTD

Balance sheet continued

As at 31 August 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 10 10
Profit and loss account: 38,834 64,349
Shareholders funds: 38,844 64,359

For the year ending 31 August 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 22 October 2023
And Signed On Behalf Of The Board By:

Name: Victor Jansson
Status: Director

The notes form part of these financial statements

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

    Plant & Machinery straight line over 5 years
    Fixtures & Fittings straight line over 5 years
    Office Equipment straight line over 5 years

    Other accounting policies

    Taxation Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 2 2

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

  • 3. Off balance sheet disclosure

    No

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

4. Dividends


2023
£

2022
£
Dividends paid 0 92,000

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

5. Tangible assets

Plant & machinery Fixtures & fittings Office equipment Total
Cost £ £ £ £
At 01 September 2022 2,279 1,881 2,078 6,238
Additions 0 0 0 0
Disposals - - - -
Revaluations - - - -
Transfers - - - -
At 31 August 2023 2,279 1,881 2,078 6,238
Depreciation
At 01 September 2022 0 0 0 0
Charge for year 946 599 519 2,064
On disposals - - - -
Other adjustments - - - -
At 31 August 2023 946 599 519 2,064
Net book value
At 31 August 2023 1,333 1,282 1,559 4,174
At 31 August 2022 2,279 1,881 2,078 6,238

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery straight line over 5 years
Fixtures & Fittings straight line over 5 years
Office equipment straigh line over 5 years

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

6. Debtors


2023
£

2022
£
Trade debtors 0 0
Prepayments and accrued income 140 0
Other debtors 0 0
Total 140 0

HEALSTACK LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

7.Creditors: amounts falling due within one year note


2023
£

2022
£
Trade creditors 156
Taxation and social security 4,318 31,404
Total 4,318 31,560